Sentence examples for progression of less from inspiring English sources

Conventional chemotherapy regimens produce 40 to 80% objective response rates with median time to progression of less than 1 year (Clavel and Catimel, 1993; Nabholtz et al, 2001).

Hence, there has been only one partial response reported among the 46 evaluable patients treated in these two trials for an aggregate response rate of 2% and a median time to progression of less than 8 weeks.

The Edinburgh Type 2 Diabetes Study is a large prospective cohort study that has the potential to identify factors that are important for the development and progression of less well-characterised complications of type 2 diabetes.

To evaluate the association between an increase in biomarkers and OS duration, patients were grouped into four categories: (1) time to progression of less than 3 months, (2) time to progression of 3 6 months, (3) time to progression of 6-12 months, and (4) no progression greater than 12 months.

No group could be defined with a freedom from progression rate of less than 70% over 6-18 months, and the worst prognostic group, which included only 53 patients, had an overall freedom from progression rate of 57% at 5 years.

Relatively little is known about the risk factors associated with the development and progression of these less prominent diabetes-related complications, although factors such as poor glycaemic control, increased inflammation, abnormal glucocorticoid metabolism and microangiopathy may be important [ 8- 12].

In this patient, progression of disease was less rapid and bone destruction less extensive than in our patient who also presented pain at the second visit, unlike the case described by Viens et al. [ 2].

Human ovarian tumour samples were classified as chemosensitive (progression-free interval of greater than 18 months) or chemoresistant (progression-free interval of less than 6 months) based on available clinical data (Additional file 1: Table S1).

Seventeen tumours were classified as chemosensitive (progression-free interval of greater than 18 months) and eleven as chemoresistant (progression-free interval of less than 8 months) using available follow-up clinical data.

Our results demonstrate that cigarette smoking is important in determining MS susceptibility but the effect on the progression of disease is less certain.

When patients were in CKD stage 1 or 2 progression of disease was less likely during therapy indicating that early specific drug treatment is essential for clinical benefit, independent of the underlying classification of GN.